TITLE

Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D4 and methacholjne in mild asthma

AUTHOR(S)
Ketchell, R. I.; D'Amato, M.; Jensen, M. W.; O'Connor, B. J.
PUB. DATE
July 2002
SOURCE
Thorax;Jul2002, Vol. 57 Issue 7, p575
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cysteinyl leukotrienes (cysteinyl-LTs) have been implicated in the pathogenesis of allergen induced airway responses. Airway responsiveness (AR) to inhaled cysteinyl-LTs is dramatically increased following allergen challenge in animal studies. The effect in man has not been evaluated. Methods: Ten mild steroid-naïve asthmatic subjects with an isolated early asthmatic response (EAR) and 21 with an additional late asthmatic response (LAR) took part in a randomised controlled crossover study to assess AR to inhaled methacholine (MCh) and cysteinyl-LT D4 (LTD4) 22 and 24 hours, respectively, after allergen challenge. Eight subjects had two further LTD4 challenges separated by a 2 week washout period to assess the reproducibility of inhaled LTD4 challenge. Results: In subjects with an isolated EAR, non-significant mean (SE) increases in AR of 0.4 (0.4) doubling doses (DD) for MCh and 0.4 (0.5) DD for LTD4 followed allergen challenge compared with control. A significant correlation between AR to MCh and LTD4 followed both control (r=0.91, 95% Cl 0.67 to 0.98; p=0.0002) and allergen challenge (r=0.79, 95% Cl 0.32 to 0.95; p=0.0063). In subjects with an additional LAR there was a significant increase in AR to MCh (1 .2 (0.3) DD, p=0.0005) following allergen challenge but no overall effect on AR to LTD4 (0.69 (0.4) DD, p=0.11). A significant correlation between AR to MCh and LTD4 was again observed (r=0.70; 95% Cl 0.38 to 0.87; p=0.0004) following control, although it was reduced following allergen challenge (r=0.48; 95% Cl 0.063 to 0.76; p=0.027). LTD4 challenge was highly reproducible with a mean difference of 0.2 (0.3) DD between challenges. Conclusions: Allergen challenge significantly increases AR to inhaled MCh but not to LTD4 in subjects with LAR. The lack of a comparable increase in AR to LTD4 is surprising. Endogenous cysteinyl-LTs are produced in abundance following allergen challenge and may enhance AR to MCh or induce a degree of tachyphylaxis to LTD4.
ACCESSION #
12998448

 

Related Articles

  • Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study. Thomas, Mike; Murray-Thomas, Tarita; Tao Fan; Williams, Tim; Taylor, Stephanie // BMC Pulmonary Medicine;2010, Vol. 10, p29 

    Background: Asthma management guidelines recommend a stepwise approach to instituting and adjusting anti-inflammatory controller therapy for children with asthma. The objective of this retrospective observational study was to describe prescribing patterns of asthma controller therapies for...

  • The Evolving Role of Leukotriene Modifiers as First Line Therapy in Mild Chronic Asthma: Modifying the Stepped Care Approach to Asthma. Pesola, Gene R // Internet Journal of Asthma, Allergy & Immunology;2002, Vol. 2 Issue 1, p22 

    The National Asthma Education and Prevention Program (NAEPP) guidelines (1) were developed by consensus by experts in the field to provide a logical approach to asthma therapy based on asthma severity as assessed by clinical symptoms and pulmonary function data. These guidelines are a good...

  • Leukotriene Inhibitors in the Treatment of Allergy and Asthma. Scow, Dean Thomas; Luttermoser, Gary K.; Dickerson, Keith Scott // American Family Physician;1/1/2007, Vol. 75 Issue 1, p65 

    Leukotriene inhibitors are the first new class of medications for the treatment of persistent asthma that have been approved by the U.S. Food and Drug Administration in more than two decades. They also have been approved for the treatment of allergic rhinitis. Prescriptions of leukotriene...

  • SYNTHESIS OF MONTELUKAST SODIUM VIA A NITRILE INTERMEDIATE; SYNTHESIS AND CHARACTERIZATION OF IMPURITIES. BVVN, CHANDRA SEKHAR; KUMAR, N. RAMESH; CHAKRAVARTHY, A. KALYAN; MUKKANTI, K. // International Journal of Pharma & Bio Sciences;Jul-Sep2011, Vol. 2 Issue 3, pP.417 

    The objective is to study novel synthetic approaches for the synthesis of leukotriene receptor antagonist, Montelukast sodium. The current study also deals with synthesis and characterization of impurities of Montelukast sodium.

  • Leukotriene receptor antagonists: clinical effects. Barnes, Neil // Journal of the Royal Society of Medicine;Apr1997, Vol. 90 Issue 4, p200 

    The article presents information on the importance of leukotriene receptors in the treatment of asthma. Clinical trials show that the drugs that inhibit leukotriene synthesis have been effective in the treatment of asthma. The arachidonic acid synthesize leukotrienes. The arachidonic acid is...

  • slow-reacting substance of anaphylaxis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2145 

    A definition of the term "slow-reacting substance of anaphylaxis," which refers to the old name given to leukotrienes C4, D4, and E4, arachidonic acid metabolites that contribute to the pathophysiology of asthma, is presented.

  • Susceptibility to endotoxin induced uveitis is not reduced in mice deficient in BLT1, the high affinity leukotriene B(4) receptor. Smith J R; Subbarao K; Franc D T; Haribabu B; Rosenbaum J T // British Journal of Ophthalmology;Feb2004, Vol. 88 Issue 2, p273 

    Aim: To investigate the role of arachidonic acid derived chemotactic factor, LTB(4), in the development of endotoxin induced uveitis (EIU), using mice deficient in the BLT1 gene which encodes the high affinity LTB(4) receptor. METHODS: BLT1 gene deficient and wild type BALB/c mice were injected...

  • Challenges in the Management of Severe Asthma: Role of Current and Future Therapies. Oliveinstein, Ron; Al Jahdali, Hamdan; Alkhamis, Nouf; Halwani, Rabih; Al-Muhsen, Saleh; Hamid, Qutayba // Current Pharmaceutical Design;3/1/2011, Vol. 17 Issue 7, p703 

    No abstract available.

  • Airway smooth muscle as a target of asthma therapy: history and new directions. Janssen, Luke J.; Killian, Kieran // Respiratory Research;2006, Vol. 7, p123 

    Ultimately, asthma is a disease characterized by constriction of airway smooth muscle (ASM). The earliest approach to the treatment of asthma comprised the use of xanthines and anti-cholinergics with the later introduction of anti-histamines and anti-leukotrienes. Agents directed at ion channels...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics